Peritoneal Dialysis in the Modern Era: A Comprehensive Review of Clinical Practice, Evolving Challenges, and Technological Advancements
Clicks: 1
ID: 314154
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #251 of 254 articles by views in Yemen Journal of Medicine
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 254 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Peritoneal dialysis (PD) is a recognized renal replacement therapy (RRT) for individuals withend-stage kidney disease (ESKD), leveraging the peritoneal membrane’s ability to clear toxins and excess fluid efficiently. Since its clinical adoption in 1959, the percentage has increasedfrom approximately 12% in the United States to 73.6% in Hong Kong. PD has undergone substantial developments, including refined catheter placement techniques and effective fluid ultrafiltration, thereby increasing its accessibility and enhancing patient quality of life. PD is particularly suitable for individuals with challenging vascular access or those who want homebased treatment options. However, its benefits must be weighed against contraindications, which include current infections and insufficient patient support, which must be carefully evaluated. Frequent complications include infections such as peritonitis, catheter-associated problems, fluid overload, and metabolic disturbances. This review presents a comprehensive examination of peritoneal anatomy and physiology, indications and contraindications for PD, associated difficulties, and new advancements in biocompatible PD solutions, wearable artificial kidneys, and infection prevention methodologies. Despite advancements in treatment choices, obstacles remain in patient selection, technique survival, and psychosocial support, contributing to PD’s global underutilization (e.g., approximately 12% in the United States to 73.6% in Hong Kong). Future efforts must prioritize adopting biocompatible solutions, integrating AI and wearable technologies, and implementing personalized strategies to enhance technique survival and global accessibility.
| Reference Key |
habas2026peritoneal
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Elmukhtar Habas, Amnna Rayani, Ala Habas, Khaled Alarbi, Aml Habas, Mohamed Baghi, Eshrak Habas, Almehdi Errayes |
| Journal | Yemen Journal of Medicine |
| Year | 2026 |
| DOI |
10.63475/yjm.v5i1.0345
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.